SYT13在癌症中的研究进展

doi:10.11904/j.issn.1002-3070.2023.02.016

Abstract

CLC Number:

R730.2

ZHANG Yidan, ZHONG Rui, SUN Zhenxuan, WANG Teng, LIU Jintao. Research progress of SYT13 in cancer[J]. Journal of Practical Oncology, 2023, 37(2): 181-184.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/10.11904/j.issn.1002-3070.2023.02.016

http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/Y2023/V37/I2/181

1 Sung H,Ferlay J,Siegel RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
2 Glavan G,Schliebs R,Zivin M.Synaptotagmins in neurodegeneration[J].Anat Rec(Hoboken),2009,292(12):1849-1862.
3 Wolfes AC,Dean C.The diversity of synaptotagmin isoforms[J].Curr Opin Neurobiol,2020,63:198-209.
4 Henry D,Joselevitch C,Matthews GG,et al.Expression and distribution of synaptotagmin family members in the zebrafish retina[J].J Comp Neurol,2022,530(4):705-728.
5 Xue R,Meng H,Yin J,et al.The role of calmodulin vs.synaptotagmin in exocytosis[J].Front Mol Neurosci,2021,14:691363.
6 Von Poser C,Südhof TC.Synaptotagmin 13:structure and expression of a novel synaptotagmin[J].Eur J Cell Biol,2001,80(1):41-47.
7 Nizzardo M,Taiana M,Rizzo F,et al.Synaptotagmin 13 is neuroprotective across motor neuron diseases[J].Acta Neuropathol,2020,139(5):837-853.
8 Ofori JK,Karagiannopoulos A,Barghouth M,et al.The highly expressed calcium-insensitive synaptotagmin-11 and synaptotagmin-13 modulate insulin secretion[J].Acta Physiol(Oxf),2022,236(1):e13857.
9 Han S,Hong S,Lee D,et al.Altered expression of synaptotagmin 13 mRNA in adult mouse brain after contextual fear conditioning[J].Biochem Biophys Res Commun,2012,425(4):880-885.
10 Nakanishi K,Kanda M,Umeda S,et al.The levels of SYT13 and CEA mRNAs in peritoneal lavages predict the peritoneal recurrence of gastric cancer[J].Gastric Cancer,2019,22(6):1143-1152.
11 Kanda M,Shimizu D,Tanaka H,et al.Synaptotagmin XIII expression and peritoneal metastasis in gastric cancer[J].Br J Surg,2018,105(10):1349-1358.
12 张雨生,孙博实,迟强.miR-138靶向SYT13对胃癌细胞侵袭和迁移的影响及机制研究[J].哈尔滨医科大学学报,2021,55(55):495-499.
13 Kanda M,Kasahara Y,Shimizu D,et al.Amido-bridged nucleic acid-modified antisense oligonucleotides targeting SYT13 to treat peritoneal metastasis of gastric cancer[J].Mol Ther Nucleic Acids,2020,22:791-802.
14 Zhu H,Wu TC,Chen WQ,et al.Screening for differentially expressed genes between left-and right-sided colon carcinoma by microarray analysis[J].Oncol Lett,2013,6(2):353-358.
15 Li Q,Zhang S,Hu M,et al.Silencing of synaptotagmin 13 inhibits tumor growth through suppressing proliferation and promoting apoptosis of colorectal cancer cells[J].Int J Mol Med,2020,45(1):234-244.
16 Zhang YD,Zhong R,Liu JQ,et al.Role of synaptotagmin 13(SYT13)in promoting breast cancer and signaling pathways[J].Clin Transl Oncol,2023[Online ahead of print].
17 Ichikawa T,Shibata M,Inaishi T,et al.Synaptotagmin 13 is highly expressed in estrogen receptor-positive breast cancer[J].Curr Oncol,2021,28(5):4080-4092.
18 Skˇriˇcková J,Kadlec B,Venclíˇcek O,et al.Lung cancer[J].Cas Lek Cesk,2018,157(5):226-236.
19 Niu W,Jiang L.A seven-gene prognostic model related to immune checkpoint PD-1 revealing overall survival in patients with lung adenocarcinoma[J].Math Biosci Eng,2021,18(5):6136-6154.
20 Zhang L,Fan B,Zheng Y,et al.Identification SYT13 as a novel biomarker in lung adenocarcinoma[J].J Cell Biochem,2020,121(2):963-973.
21 Bertino G,Demma S,Ardiri A,et al.The immune system in hepatocellular carcinoma and potential new immunotherapeutic strategies[J].Biomed Res Int,2015,2015:731469.
22 Jahn JE,Best DH,Coleman WB.Exogenous expression of synaptotagmin XIII suppresses the neoplastic phenotype of a rat liver tumor cell line through molecular pathways related to mesenchymal to epithelial transition[J].Exp Mol Pathol,2010,89(3):209-216.
23 Jahn JE,Coleman WB.Re-expression of tumorigenicity after attenuation of human synaptotagmin 13 in a suppressed microcell hybrid cell line[J].Int J Oncol,2008,32(2):441-449.
24 Lu J,Liu Q,Zhu L,et al.Endothelial cell-specific molecule 1 drives cervical cancer progression[J].Cell Death Dis,2022,13(12):1043.

[1]	WANG Jing, DU Jing, SU Jianting, LIU Qingping, WANG Ping, WEI Zaihua. Esophageal cancer death trends in Beijing from 1990 to 2019:an age-period-cohort model analysis [J]. Journal of Practical Oncology, 2023, 37(2): 97-101.
[2]	ZHOU Hairong, WANG Weiwei, WANG Chenchen, HONG Xin. Analysis on the long-term trend of mortality and years of life lost of stomach in Nanjing,2007—2019 [J]. Journal of Practical Oncology, 2023, 37(2): 102-106.
[3]	ZHANG Xin, WU Xianmei, LI Hong, LIU Xiaozhou, KONG Dewen, CHEN Zhuo. The disease burden of breast cancer attributed to metabolic risk factors in the Chinese female population,from 1990 to 2019 [J]. Journal of Practical Oncology, 2023, 37(2): 107-111.
[4]	ZHU Xiaoyun, GAO Xia, WANG Qian, SHU Qi. Analyses of colorectal cancer screening results among community residents in Jinshan district,Shanghai,2013—2021 [J]. Journal of Practical Oncology, 2023, 37(2): 112-116.
[5]	LONG Chaolian, LI Kun, LIU Zichen, ZHANG Nana, CHE Nanying. The correlation between the expression of programmed death ligand 1 in non-small cell lung cancer and clinical pathological features and common driver gene mutation [J]. Journal of Practical Oncology, 2023, 37(2): 117-122.
[6]	LIU Jing, CHU Yanjie, PEI Fenghua, XU Ruiling, WANG Yanbo. Role and mechanism of lncRNA AP000487.1 in esophageal cancer [J]. Journal of Practical Oncology, 2023, 37(2): 123-129.
[7]	WANG Bingping, DUAN Jinkai, ZHANG Shuang, GAO Yanwei, REN Meng, CHEN Liangquan, GAO Weishi. Research on NK cells combined with PD-1 monoclonal antibody to kill colorectal cancer cells [J]. Journal of Practical Oncology, 2023, 37(2): 130-136.
[8]	XIA Jianhong, ZHOU Liqing, YAN Yan, MA Tingting, SU Xinyu. The function and mechanism of lncRNA DUXAP8 in endometrial cancer cells [J]. Journal of Practical Oncology, 2023, 37(2): 137-143.
[9]	LIU Xinxin, MA Xiyuan, MIU Meiqi, WANG Yuqing, CHEN Jing. Research progress on the role of IL-6 and its receptor in the treatment of breast cancer [J]. Journal of Practical Oncology, 2023, 37(2): 149-154.
[10]	FENG Chengtian, HUANG Furong, JIANG Yongdong. Research progress of lipid metabolism on the mechanism of drug resistance to trastuzumab therapy in breast cancer [J]. Journal of Practical Oncology, 2023, 37(2): 155-159.
[11]	WANG Yichun, WEI Hong, HAN Ye, SUN Jiawie, WANG Xiaolei. Application progress of multimodal ultrasound in the diagnosis of peripheral pulmonary benign and malignant lesions [J]. Journal of Practical Oncology, 2023, 37(2): 164-169.
[12]	CHEN Liming, XIA Min. Research progress in the mechanism of m6A-modified reading protein YTH in colorectal cancer [J]. Journal of Practical Oncology, 2023, 37(2): 170-174.
[13]	WEN Shichao, WANG Jingxuan. Research status of copper-dependent cell death and copper in breast cancer [J]. Journal of Practical Oncology, 2023, 37(2): 185-189.
[14]	MING Cheng, WU Yun. Research progress of Wnt/β-catenin signaling pathway and its inhibitors in gastric cancer [J]. Journal of Practical Oncology, 2023, 37(2): 190-194.
[15]	ZHOU Mengmeng, XU Wenchao, YU Hao. Analysis of disease burden of prostate cancer among men in Jiangsu province from 1990 to 2019 [J]. Journal of Practical Oncology, 2023, 37(1): 1-5.

Research progress of SYT13 in cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments